Ninety One North America Inc. Sells 557 Shares of CME Group Inc. $CME

Ninety One North America Inc. decreased its stake in CME Group Inc. (NASDAQ:CME) by 15.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,075 shares of the financial services provider’s stock after selling 557 shares during the period. Ninety One North America Inc.’s holdings in CME Group were worth $848,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of CME. Merit Financial Group LLC grew its holdings in shares of CME Group by 105.8% in the 1st quarter. Merit Financial Group LLC now owns 11,929 shares of the financial services provider’s stock valued at $3,165,000 after acquiring an additional 6,132 shares in the last quarter. Unigestion Holding SA grew its holdings in shares of CME Group by 5.0% in the 1st quarter. Unigestion Holding SA now owns 101,716 shares of the financial services provider’s stock valued at $26,971,000 after acquiring an additional 4,819 shares in the last quarter. Teamwork Financial Advisors LLC bought a new position in shares of CME Group in the 1st quarter valued at about $226,000. Nixon Peabody Trust Co. bought a new position in shares of CME Group in the 1st quarter valued at about $241,000. Finally, Portside Wealth Group LLC grew its holdings in shares of CME Group by 2.1% in the 1st quarter. Portside Wealth Group LLC now owns 3,878 shares of the financial services provider’s stock valued at $1,029,000 after acquiring an additional 78 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In other news, Director William R. Shepard acquired 262 shares of the stock in a transaction on Thursday, September 25th. The stock was acquired at an average cost of $265.19 per share, for a total transaction of $69,479.78. Following the completion of the transaction, the director directly owned 258,459 shares in the company, valued at approximately $68,540,742.21. This trade represents a 0.10% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, General Counsel Jonathan L. Marcus sold 392 shares of the business’s stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the transaction, the general counsel owned 7,851 shares of the company’s stock, valued at approximately $2,056,962. This represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,043 shares of company stock valued at $3,527,956 in the last three months. Corporate insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Oppenheimer raised their price objective on CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a report on Thursday, July 24th. Barclays set a $298.00 price target on CME Group and gave the stock an “equal weight” rating in a report on Thursday, July 24th. JPMorgan Chase & Co. lifted their price target on CME Group from $246.00 to $252.00 and gave the stock an “underweight” rating in a report on Thursday, September 25th. Citigroup upgraded CME Group from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $275.00 to $300.00 in a report on Thursday, September 25th. Finally, Piper Sandler lifted their price target on CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a report on Tuesday, July 15th. Five equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, CME Group has an average rating of “Hold” and an average price target of $268.14.

CME Group Stock Down 0.8%

NASDAQ CME opened at $270.19 on Wednesday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 1-year low of $213.94 and a 1-year high of $290.79. The company has a 50 day moving average of $270.73 and a 200-day moving average of $271.13. The company has a market cap of $97.37 billion, a price-to-earnings ratio of 26.16, a PEG ratio of 4.93 and a beta of 0.43.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the previous year, the business earned $2.56 earnings per share. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. On average, equities research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s payout ratio is presently 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.